RE:RE:RE:The Parade!HailMary wrote:
One area that we will disagree on I'm sure. I am not confident that the drug ever gets to market. Odds are stacked against ATE, with only 1/5000 new drugs ever getting that far. Phase 3 will involve 2000-3000 participants, will take upwards of 2-3 years to complete, and is going to cost a lot of money. Most of that many will be raised off the backs of current shareholders thru more dilution, and with any luck, some assistance from a future partner.
Well, at least you know how 'high risk' BioTech/Pharma investing works. If it's not for you, then fine. But we still won't accpet your data without you disclosing the source of such information. For you see, this is also another piece of wise investing, figuring out where to place credibility. Right now you still have zero. Because of your stubbornness. :)
And before you try and turn this against me, let me state that I have not presented any questionable stats/data that requires me to reveal a source of my posting. Therefore, my credibility has not come into play. And when I do post factual information or data.....I always include a link, document, quote, to prove my source.